Determinants of China's Health Expenditure Growth: Based on Baumol’s Cost Disease Theory

DOI: https://doi.org/10.21203/rs.3.rs-261686/v1

Abstract

Background During the past four decades, China's total health expenditure and health expenditure per capita have both experienced a dramatically increase in growth rate. It is essential to understand the driven force of this growth with the new economic context. This study aims to explore the determinants of health expenditure growth and the influencing mechanism of these determinants, with considering the productivity efficiency represented by Baumol's cost disease.

Methods Based on the longitudinal data of 30 provincial-level administrative regions in China, from 2010 to 2017, multi-variates regression models were constructed to assess the determinants, including demography, income, Baumol's cost disease, technology, their effects on per capital total health expenditure growth and the three financing sources: government, society and out-of-pocket health expenditure. Moreover, the Spatial Durbin Model was used to analyze the influence mechanism of each factor on the increase of health expenditure across provinces.

Results Among 210 province-year observations, all of the average growth rate of total health expenditure (12.78%) was much higher than the growth rate of per capita real GDP (8.06%). According to the statistical analysis, we found that:(1) Income and Baumol’s cost disease have significant positive impact on health expenditure growth(P<0.01). The impact of technical factors on government health expenditure is significantly positive. (2) The determinants affected the growth of health costs in different regions variably, the eastern region is mainly driven by Baumol's cost disease and technical factors, while the central and western regions are mainly affected by income factors and Baumol's cost disease. (3) There is a significant spatial spillover effect on the health expenditure growth between regions. The income factor and Baumol’s cost disease have a positive impact on the health expenditure growth in its own region as well as in other regions.

Conclusions Income and Baumol's cost disease significantly contributed to China health expenditure increase growth. The health expenditure determinants showed spatial varies effect and space spillover effect on the neighborhood areas. Which indicates that a reasonable salary system should be contrasted to meet the changeling from the Baumol's cost disease, and the necessary of equity in health resource allocation among provinces in China. 

Full Text

This preprint is available for download as a PDF.

Tables

Due to technical limitations, table 1 docx is only available as a download in the Supplemental Files section.

 

Table 2

Characteristics of the 30 study provinces from 2010 to 2017

 

N

Mean

SD

Min

Max

Outcome Variables

         

dlnTHE

210

0.1278

0.0510

-0.0021

0.2794

dlnGHE

210

0.1229

0.0663

-0.0587

0.3074

dlnSHE

210

0.1622

0.0855

-0.1923

0.3751

dlnOOP

210

0.0946

0.0730

-0.1445

0.2917

Determinants

         

dlnGDP

210

0.0806

0.0236

-0.0238

0.1495

dlnPOP65

210

0.0348

0.0674

-0.2512

0.2808

BV

210

0.3387

1.1036

-2.5498

7.1072

dlnRD

210

0.0304

0.0679

-0.2559

0.2857

Control Variables

         

dlnBED

210

0.0608

0.0759

-0.4926

0.3653

dlnDOC

210

0.0511

0.1132

-0.4837

0.5690

dlnOUTP

210

0.0403

0.0346

-0.0454

0.1363

dlnINP

210

0.0704

0.0469

-0.0364

0.2355

 

Table 3

The effects of determinants on the per capita health expenditure

 

(1)

(2)

(3)

(4)

(5)

(6)

(7)

Variables

THE

THE

THE

THE

GHE

SHE

OOP

dlnGDP

0.869***

0.804***

0.799***

0.890***

1.569***

0.574*

0.732**

 

(0.194)

(0.192)

(0.195)

(0.216)

(0.319)

(0.343)

(0.326)

BV

0.0268***

0.0246***

0.0245***

0.0260***

0.0243***

0.0365***

0.0189***

 

(0.00383)

(0.00378)

(0.00386)

(0.00405)

(0.00571)

(0.00697)

(0.00568)

dlnRD

 

0.116

0.115

0.114

0.208**

0.106

0.0984

   

(0.0721)

(0.0720)

(0.0730)

(0.0927)

(0.0992)

(0.103)

dlnPOP65

   

-0.0118

0.00139

0.0576

-0.0350

-0.0197

     

(0.0470)

(0.0463)

(0.0553)

(0.0753)

(0.0787)

dlnBED

     

-0.00597

0.109*

-0.0840

0.0546

       

(0.0549)

(0.0591)

(0.0791)

(0.0862)

dlnDOC

     

-0.0297

-0.0980***

0.00755

-0.00400

       

(0.0297)

(0.0305)

(0.0549)

(0.0527)

dlnOUTP

     

0.110

-0.127

0.122

0.354*

       

(0.126)

(0.172)

(0.226)

(0.196)

dlnINP

     

-0.114

-0.421***

0.0464

-0.101

       

(0.0964)

(0.116)

(0.164)

(0.139)

Constant

0.0537***

0.0558***

0.0566***

0.0541***

0.0177

0.105***

0.0202

 

(0.0162)

(0.0155)

(0.0162)

(0.0171)

(0.0251)

(0.0256)

(0.0238)

Observations

210

210

210

210

210

210

210

R-squared

0.133

0.166

0.190

0.199

0.228

0.144

0.110

Note: Robust standard deviations in brackets, ***, ** and * indicate significant at the 1%, 5% and 10% levels respectively. all variables are in first differenced logarithms and at 2000 GDP price levels; adjusted Baumol variable= (real wage rate - labour productivity) * 1/(share of Baumol sector in total employment)

 

Table 4

The effects of determinants on the per capita health expenditure in different regions

 

(1)

(2)

(3)

Variables

Eastern Region

Central Region

Western Region

dlnGDP

0.372

1.028**

1.201***

 

(0.377)

(0.475)

(0.292)

BV

0.0173**

0.0384***

0.0268***

 

(0.00693)

(0.0127)

(0.00678)

dlnPOP65

-0.0620

-0.0128

0.135

 

(0.0642)

(0.109)

(0.0847)

dlnRD

0.292***

-0.0956

0.0867

 

(0.0997)

(0.0963)

(0.120)

dlnBED

0.00859

0.181

-0.0275

 

(0.0592)

(0.185)

(0.181)

dlnDOC

-0.0285

0.0103

-0.0643

 

(0.0364)

(0.116)

(0.104)

dlnOUTP

0.0173

0.437**

-0.162

 

(0.160)

(0.198)

(0.285)

dlnINP

-0.0176

-0.259

-0.173

 

(0.140)

(0.182)

(0.178)

Constant

0.0854***

0.0288

0.0432

 

(0.0287)

(0.0401)

(0.0281)

Observations

77

56

77

R-squared

0.299

0.267

0.253

Number of prov

11

8

11

Note: Robust standard deviations in brackets, ***, ** and * indicate significant at the 1%, 5% and 10% levels respectively.

 

Table 5

Spatial Durbin Model estimation results of factors influencing health expenditure growth

 

Fixed effects

Fixed effects

Fixed effects

Fixed effects

Random effects

Random effects

Random effects

Random effects

Variables

THE

GHE

SHE

OOP

THE

GHE

SHE

OOP

dlnPOP65

0.0278

0.117***

-0.00911

0.00212

0.0193

0.113***

-0.0538

0.0052

 

(0.0536)

(0.0334)

(0.0725)

(0.0936)

(0.0541)

(0.0401)

(0.0718)

(0.0941)

dlnGDP

0.732**

-0.0151

1.237**

0.606

0.533**

0.278

1.151***

0.308

 

(0.35)

(0.473)

(0.546)

(0.546)

(0.27)

(0.325)

(0.426)

(0.465)

BV

0.0310***

0.0219***

0.0439***

0.0254***

0.0257***

0.0205***

0.0368***

0.0215***

 

(0.00518)

(0.00633)

(0.0087)

(0.00681)

(0.00388)

(0.00536)

(0.00606)

(0.00511)

dlnRD

0.181***

0.157*

0.275***

0.147

0.151***

0.253***

0.155**

0.103

 

(0.0679)

(0.0924)

(0.0743)

(0.0912)

(0.0571)

(0.0707)

(0.0639)

(0.0763)

dlnBED

0.00906

0.176*

-0.203**

0.162**

0.00982

0.154**

-0.141

0.112

 

(0.0542)

(0.0907)

(0.101)

(0.0699)

(0.063)

(0.0673)

(0.106)

(0.0971)

dlnDOC

-0.0221

-0.0886***

0.0193

-0.00863

-0.0235

-0.0824***

0.0353

-0.0199

 

(0.0273)

(0.0201)

(0.0481)

(0.0502)

(0.0309)

(0.0174)

(0.0459)

(0.0601)

dlnOUTP

0.167

-0.232

0.409

0.484*

-0.0272

-0.441***

0.229

0.139

 

(0.133)

(0.184)

(0.312)

(0.256)

(0.126)

(0.154)

(0.276)

(0.199)

dlnINP

-0.0926

-0.204

0.278

-0.506**

0.00698

-0.0891

0.302

-0.323**

 

(0.174)

(0.159)

(0.299)

(0.226)

(0.116)

(0.109)

(0.233)

(0.155)

W*dlnPOP65

0.0912

-0.104

0.908

-0.0771

-0.384*

-0.467

-0.369

-0.223

 

(0.426)

(0.37)

(0.674)

(0.521)

(0.202)

(0.296)

(0.323)

(0.359)

W*dlnGDP

5.165***

-2.931

12.33***

4.878

1.651**

1.730*

0.308

0.509

 

(1.503)

(2.782)

(3.304)

(3.553)

(0.657)

(0.996)

(0.826)

(0.932)

W*BV

0.115***

0.0193

0.227***

0.105*

0.0108

-0.000971

0.0342

-0.0125

 

(0.0364)

(0.0384)

(0.0645)

(0.0583)

(0.0125)

(0.0151)

(0.0219)

(0.0144)

W*dlnRD

0.965*

-0.0538

1.826**

0.739

1.016***

0.403

1.385***

0.868**

 

(0.576)

(0.597)

(0.788)

(0.626)

(0.325)

(0.369)

(0.348)

(0.362)

W*dlnBED

0.763

0.619

-0.412

1.953***

0.0733

0.0322

-0.0833

0.459

 

(0.483)

(0.442)

(0.669)

(0.672)

(0.269)

(0.352)

(0.466)

(0.432)

W*dlnDOC

-0.376*

-0.155

-0.198

-0.711**

-0.145

-0.0509

-0.313

-0.106

 

(0.215)

(0.18)

(0.303)

(0.306)

(0.149)

(0.13)

(0.237)

(0.239)

W*dlnOUTP

2.026*

1.182

2.225

4.084**

-0.751**

-0.082

-1.065*

-0.273

 

(1.208)

(1.364)

(1.964)

(1.94)

(0.382)

(0.578)

(0.646)

(0.643)

W*dlnINP

-1.654

-1.444*

-1.058

-2.985**

-0.341

-0.468

-0.469

0.0966

 

(1.111)

(0.758)

(1.861)

(1.383)

(0.235)

(0.315)

(0.372)

(0.454)

rho

-0.434**

-0.666**

-0.890***

-0.467***

-0.087

0.412***

-0.377*

0.14

 

(0.205)

(0.261)

(0.225)

(0.175)

(0.178)

(0.134)

(0.197)

(0.106)

lgt_theta

       

14.84***

14.73***

17.67***

16.26***

         

(0.217)

(0.372)

(0.257)

(0.32)

sigma2_e

0.00151***

0.00168***

0.00467***

0.00357***

0.00177***

0.00212***

0.00561***

0.00441***

 

(0.00019)

(0.000302)

(0.000595)

(0.000546)

(0.000228)

(0.000374)

(0.000714)

(0.000601)

Constant

       

-0.00657

-0.0434

0.137***

-0.0152

         

(0.0283)

(0.0485)

(0.0447)

(0.0405)

Observations

210

210

210

210

210

210

210

210

R-squared

0.193

0.007

0.032

0.087

0.316

0.512

0.217

0.165

Number of prov

30

30

30

30

30

30

30

30

Note: Robust standard deviations in brackets, ***, ** and * indicate significant at the 1%, 5% and 10% levels respectively.

 

Table 6

Decomposition of spatial effect of the determinants on the health expenditure

 

THE

GHE

SHE

OOP

 

(1)

(2)

(3)

(4)

(5)

(6)

(7)

(8)

(9)

(10)

(11)

(12)

Variables

Direct effects

Indirect effects

Total effects

Direct effects

Indirect effects

Total effects

Direct effects

Indirect effects

Total effects

Direct effects

Indirect effects

Total effects

dlnPOP65

0.0285

0.103

0.131

0.123***

-0.0847

0.0380

-0.0377

0.548

0.511

0.00694

-0.0171

-0.0101

 

(0.0541)

(0.311)

(0.321)

(0.0375)

(0.243)

(0.234)

(0.0700)

(0.380)

(0.390)

(0.0935)

(0.365)

(0.402)

dlnGDP

0.629*

3.699***

4.327***

0.0444

-1.742

-1.698

0.834

6.508***

7.342***

0.496

3.492

3.988

 

(0.349)

(1.336)

(1.300)

(0.478)

(1.742)

(1.609)

(0.561)

(1.906)

(1.878)

(0.560)

(2.732)

(2.529)

BV

0.0296***

0.0783***

0.108***

0.0223***

0.00533

0.0276

0.0379***

0.110***

0.148***

0.0241***

0.0705*

0.0946**

 

(0.00460)

(0.0299)

(0.0314)

(0.00587)

(0.0238)

(0.0254)

(0.00797)

(0.0399)

(0.0413)

(0.00634)

(0.0422)

(0.0417)

dlnRD

0.164**

0.671

0.835*

0.159*

-0.0899

0.0687

0.223***

0.920**

1.143***

0.133

0.479

0.611

 

(0.0653)

(0.414)

(0.446)

(0.0934)

(0.384)

(0.370)

(0.0600)

(0.409)

(0.423)

(0.0844)

(0.439)

(0.477)

dlnBED

-0.00317

0.548

0.545

0.163*

0.308

0.471*

-0.191*

-0.149

-0.340

0.130*

1.334**

1.464***

 

(0.0568)

(0.369)

(0.356)

(0.0890)

(0.249)

(0.281)

(0.111)

(0.398)

(0.353)

(0.0738)

(0.547)

(0.524)

dlnDOC

-0.0150

-0.263

-0.278*

-0.0855***

-0.0539

-0.139

0.0273

-0.117

-0.0899

0.00544

-0.496**

-0.491**

 

(0.0297)

(0.173)

(0.157)

(0.0196)

(0.109)

(0.112)

(0.0548)

(0.195)

(0.167)

(0.0523)

(0.240)

(0.217)

dlnOUTP

0.135

1.488*

1.623*

-0.262

0.858

0.595

0.341

1.142

1.483

0.406

2.808**

3.215**

 

(0.139)

(0.904)

(0.949)

(0.183)

(0.839)

(0.898)

(0.312)

(1.117)

(1.201)

(0.260)

(1.422)

(1.586)

dlnINP

-0.0698

-1.186

-1.256

-0.183

-0.772*

-0.955**

0.309

-0.702

-0.393

-0.460*

-1.987*

-2.448**

 

(0.189)

(0.877)

(0.810)

(0.150)

(0.448)

(0.475)

(0.338)

(1.150)

(0.990)

(0.252)

(1.179)

(1.054)

Note: Columns 1–3 show growth in real health expenditure per capita, columns 4–6 show growth in real government health expenditure per capita, columns 7–9 show growth in real social health expenditure per capita, and columns 10–12 show growth in personal cash health expenditure per capita. Robust standard deviations are in parentheses, with ***, ** and * indicating significant at the 1%, 5% and 10% levels respectively.